I am posting this news since it may relate directly to Indiva Life THC Lozenges which are also being sold as an extract in packages greater than 10mg. I would not be surprised if Indiva gets a similar notice from Health Canada, which if announced, may have a negative impact on the already low share price.
Organigram Provides Edison JOLTS Product Update 2023-03-13 08:32:03 AM ET (MT Newswires)
08:32 AM EDT, 03/13/2023 (MT Newswires) -- Organigram Holdings Inc. (TSX: OGI; NASDAQ: OGI), announced Wednesday that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format have been improperly classified as an "extract" rather than an "edible" under the Cannabis Regulations.
A statement noted the company launched the products in August 2021. The company said it "remains of the view that the patent pending products are properly classified as cannabis extracts and compliant with the Cannabis Regulations, and is assessing its options with its legal advisors". At present, the company has paused production of the products in the current packaging format, pending resolution of the matter. According to Health Canada's notification, the company can continue to sell and distribute inventory of the products until May 31, 2023.